Demo Sign up Log In

Nuo Therapeutics, Inc. (AURX)

Cost of Revenue

$1.87M

TTM · Period ending: Jun 30, 2026 · USD

AURX Cost of Revenue

Latest reported$1.87Mperiod endingJun 30, 2026

Latest reported$1.87Mperiod endingJun 30, 2026

AURX Cost of Revenue ($25.87K → $1.87M)

Annual cost of revenue

High-resolution chart · PNG

AURX cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuo Therapeutics, Inc. Cost of Revenue — Annual fiscal periods (USD)
Period ending	Cost of Revenue (USD)
Dec 31, 2025	1,095,553
Dec 31, 2024	302,842
Dec 31, 2023	126,092
Dec 31, 2022	19,214
Dec 31, 2021	0
Dec 31, 2020	0
Dec 31, 2019	114,614
Dec 31, 2018	162,993
Dec 31, 2017	1,091,042
Dec 31, 2016	1,987,688
Dec 31, 2015	7,967,110
Dec 31, 2014	6,770,743
Dec 31, 2013	8,453,192
Dec 31, 2012	3,914,542
Dec 31, 2011	2,727,156
Dec 31, 2010	1,612,950
Dec 31, 2009	458,805
Dec 31, 2008	601,020
Dec 31, 2007	850,285
Dec 31, 2006	1,014,585
Dec 31, 2005	881,324
Dec 31, 2004	711,827
Dec 31, 2003	758,433
Dec 31, 2002	62,047
Dec 31, 2001	0
Dec 31, 2000	61,952
Dec 31, 1999	25,870

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.